34 results on '"Alghamdi, Balgees"'
Search Results
2. EPAS1-related pheochromocytoma/ paraganglioma.
3. Germline Variants in Sporadic Pituitary Adenomas.
4. Hereditary vitamin D resistant rickets (HVDRR) case series: phenotype, genotype, conventional treatment, and adjunctive cinacalcet therapy
5. How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?
6. THU614 Neurofibromatosis Type 1 Presenting With Pheochromocytoma And Severe Vascular And Hematological Manifestations Due To A Novel NF1 Mutation
7. THU683 TERT Promoter Mutations, But Not BRAFV600EMutation, Correlate With The American Thyroid Association And TNM Staging Systems And Predict Outcome Of Differentiated Thyroid Cancer
8. SAT604 An Extensively Invasive Giant Prolactinoma Associated With CDH23 Mutation
9. SAT631 EPAS1 Mutations In Three Adjacent Nucleotides Resulting In Different Phenotypes
10. Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer
11. Molecular Genetics of Diffuse Sclerosing Papillary Thyroid Cancer
12. Thyroid Cancer, Neuroendocrine Tumor, Adrenal Adenoma, and Other Tumors in a Patient With a Germline PMS1 Mutation
13. How do BRAFV600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?
14. A CYP11A1 homozygous exonic variant inducing an alternative splicing, frameshift and truncation in a family with congenital adrenal hyperplasia
15. Case Report: Severe Gonadal Dysgenesis Causing 46,XY Disorder of Sex Development Due to a Novel NR5A1 Variant
16. A Unique Mechanism of a Novel SynonymousPHEXVariant Causing X-Linked Hypophosphatemia
17. Fumarate Hydratase is a Novel Gene for Familial Non-Medullary Thyroid Cancer
18. Papillary Thyroid Cancer and a TERT Promotor Mutation-positive Paraganglioma in a Patient With a Germline SDHB Mutation
19. Clinical and pathological features and phenotype-genotype correlation of pheochromocytoma and paraganglioma in a highly consanguineous population
20. A single-centre study of genetic mutations, audiology, echocardiogram and pulmonary function in Saudi children with osteogenesis imperfecta
21. Controversy on the management of patients carrying RET p.V804M mutation
22. Controversy on the Management of Patients Carrying RET p.V804M Mutation
23. A Unique Mechanism of a Novel Synonymous PHEX Variant Causing X-Linked Hypophosphatemia.
24. A Unique Mechanism of a Novel Synonymous PHEXVariant Causing X-Linked Hypophosphatemia
25. A single-centre study of genetic mutations, audiology, echocardiogram and pulmonary function in Saudi children with osteogenesis imperfecta.
26. Controversy on the management of patients carrying RETp.V804M mutation
27. Correction to: Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer
28. Absence of EIF1AX, PPM1D, and CHEK2 mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer
29. Lung Metastasis in Pediatric Thyroid Cancer: Radiological Pattern, Molecular Genetics, Response to Therapy, and Outcome
30. Lung Metastasis in Pediatric Thyroid Cancer: Radiological Pattern, Molecular Genetics, Response to Therapy, and Outcome.
31. Absence of EIF1AX, PPM1D, and CHEK2mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer
32. Correction to: Absence of EIF1AX, PPM1D, and CHEK2mutations reported in Thyroid Cancer Genome Atlas (TCGA) in a large series of thyroid cancer
33. EPAS1-related pheochromocytoma/paraganglioma.
34. How do BRAF V600E and TERT promoter mutations interact with the ATA and TNM staging systems in thyroid cancer?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.